Solara Active Pharma Sciences Limited
NSE:SOLARA.NS
641.85 (INR) • At close July 31, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 5.4 | -4,884.2 | -448.1 | -911 | 2,215 | 1,149.1 | 577.76 | 1.97 | -0.396 |
| Depreciation & Amortization
| 992.5 | 1,033.3 | 1,112.1 | 1,123.2 | 1,086.6 | 941.6 | 837.04 | 367.09 | 0 |
| Deferred Income Tax
| 0 | 0 | 192.7 | -31.9 | -347.4 | -186.7 | -202.71 | 0 | 0 |
| Stock Based Compensation
| 26.8 | 6 | 0.5 | -13.1 | 51.4 | 56 | 23.89 | 0 | 0 |
| Change In Working Capital
| 30.2 | 1,906.3 | 7.2 | -3,137.9 | -2,058.4 | -164.5 | -317.96 | -108.39 | 0 |
| Accounts Receivables
| 198.1 | 1,781.7 | -528 | -145.5 | -2,573.7 | 678 | -553.4 | -391.82 | 0 |
| Inventory
| 418 | 130.8 | 173.2 | -2,805.8 | -152.4 | -657.9 | -307.9 | -269.39 | 0 |
| Accounts Payables
| -594.3 | 73 | 389 | -238.8 | 966.7 | -280.5 | -509.8 | 444.18 | 0 |
| Other Working Capital
| 8.4 | -79.2 | -27 | 52.2 | -299 | 95.9 | 1,053.14 | 161 | 0 |
| Other Non Cash Items
| 1,073.3 | 3,027.3 | 698.1 | 550.4 | 607.4 | 646.7 | 680.61 | 231.56 | 0.396 |
| Operating Cash Flow
| 2,128.2 | 1,088.7 | 1,562.5 | -2,420.3 | 1,554.6 | 2,442.2 | 1,598.63 | 492.23 | 0 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -399.4 | -410.6 | -1,113.1 | -2,086.2 | -1,744.8 | -2,688.7 | -525.43 | -347.36 | 0 |
| Acquisitions Net
| 9.6 | 0 | -12.8 | 1.3 | -1 | -550.1 | -638.57 | -509 | 0 |
| Purchases Of Investments
| 0 | 0 | -12.8 | 0 | 0 | -500 | -4 | 0 | 0 |
| Sales Maturities Of Investments
| 9.6 | 0 | 12.8 | 0 | 0 | 91.8 | 4 | 0 | 0 |
| Other Investing Activites
| 11.9 | 375.5 | 314.5 | -343.6 | 682.8 | 58.9 | 71.77 | 1.68 | 0 |
| Investing Cash Flow
| -368.3 | -35.1 | -811.4 | -2,428.5 | -1,063 | -3,588.1 | -1,092.23 | -854.68 | 0 |
| Financing Activities: | |||||||||
| Debt Repayment
| -2,213.8 | -21.4 | -228.8 | 4,173.1 | -1,001.5 | 1,635.6 | -880.7 | 528.31 | 0 |
| Common Stock Issued
| 1,561.3 | 0 | 0 | 29 | 2,981.6 | 297.6 | 1,480 | 0.1 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | -107.8 | -197.3 | -156.2 | 0 | 0 | 0 |
| Other Financing Activities
| -1,152.3 | -1,035.1 | -898.8 | -758.6 | -857.9 | -827.9 | -891.1 | 148.96 | 1.2 |
| Financing Cash Flow
| -1,804.8 | -1,056.5 | -1,127.6 | 3,335.7 | 924.9 | 949.1 | -233.84 | 677.37 | 1.2 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 25.13 | 0 | 0 |
| Net Change In Cash
| -44.9 | -2.9 | -376.5 | -1,513.1 | 1,416.5 | -196.8 | 297.69 | 314.92 | 1.2 |
| Cash At End Of Period
| 39.5 | 84.4 | 87.3 | 463.8 | 1,976.9 | 560.4 | 757.21 | 459.52 | 1.2 |